bioAffinity Technologies (BIAF) Other Non-Current Assets (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Other Non-Current Assets of $12816.0 for Q1 2026, down 34.86% year-over-year from $19675.0 in Q1 2025, and little changed quarter-over-quarter from $12815.0 in Q4 2025.
bioAffinity Technologies (BIAF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Other Non-Current Assets for 6 consecutive years, with $12816.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 34.86% year-over-year to $12816.0; the TTM figure through Mar 2026 stood at $12816.0 (down 34.86% YoY), while the FY2025 annual figure was $12815.0, down 34.87% from the prior year.
- Other Non-Current Assets held at $12816.0 in Q1 2026 per BIAF's latest filing, from $12815.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $19676.0 in Q3 2024 and bottomed at $6000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $13598.8 across 5 years, with a median of $12816.0 in 2026.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 184.32% — and 2025, when it plunged 34.87%.
- bioAffinity Technologies' Other Non-Current Assets stood at $6000.0 in 2022, then jumped by 167.67% to $16060.0 in 2023, then gained by 22.52% to $19676.0 in 2024, then tumbled by 34.87% to $12815.0 in 2025, then gained by 0.01% to $12816.0 in 2026.
- Business Quant data shows BIAF's Other Non-Current Assets at $12816.0 in Q1 2026, $12815.0 in Q4 2025, and $12815.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 49.99 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 567.73 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 769.30 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 16,709.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16,709.00 |
| Mar 31, 2026 | 12,816.00 |
| Dec 31, 2025 | 12,815.00 |
| Sep 30, 2025 | 12,815.00 |
| Jun 30, 2025 | 12,814.00 |
| Mar 31, 2025 | 19,675.00 |
| Dec 31, 2024 | 19,676.00 |
| Sep 30, 2024 | 19,676.00 |
| Jun 30, 2024 | 19,675.00 |
| Mar 31, 2024 | 16,060.00 |
| Dec 31, 2023 | 16,060.00 |
| Sep 30, 2023 | 16,060.00 |
| Jun 30, 2023 | 6,920.00 |
| Mar 31, 2023 | 6,920.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Dec 31, 2021 | 7,942.00 |